Skip to content
healthcare.dev

VANFLYTA

NDC 65597-511, QUIZARTINIB, tablet, film coated, from Daiichi Sankyo Inc..

Product NDC
65597-511
Status
Listed
Labeler
Daiichi Sankyo Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216993
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65597-511 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • QUIZARTINIB DIHYDROCHLORIDE26.5 mg/1

Pharmacologic classes

FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA]; Kinase Inhibitor [EPC]

Package NDCNDC-11Package
65597-511-04655970511041 BOTTLE in 1 CARTON (65597-511-04) / 14 TABLET, FILM COATED in 1 BOTTLE
65597-511-28655970511281 BOTTLE in 1 CARTON (65597-511-28) / 28 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/29cdbcfe-497d-4e78-bb7b-2d4acafe8e86

Use it

Look up 65597-511 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65597-511 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65597-511. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.